Abuja - The African Collaborative Centre for Microbiome and Genomics Research at the University College Hospital in Ibadan will receive more than $4.16 million over four years to fight cervical cancer.
The funds will be received as part of initiatives by the United States expanding its partnership with African institutions and scientists for research into some of the most vexing health problems plaguing the continent and world.
This was disclosed in a document obtained from the America embassy in Abuja on Tuesday.
According to the document, the National Institutes of Health (NIH) in October 18 announced 10 new grants totalling up to $17 million over the next four years.
The new awards include funding for two collaborative centres, one that will study the risk factors for stroke and another that will study the role of the human vaginal microbiome in cervical cancer.
Cervical cancer is the most common cancer in Africa, NIH said.
This grant will focus on the epidemiology of cervical cancer and human papillomavirus infection.
“It addresses a high-impact public health challenge that affects women’s health in Africa and the rest of the world,” NIH said.
In addition to research, this centre will provide postdoctoral training for qualified candidates from across Africa in research methods, epidemiology, bioinformatics, data management and laboratory methods.
The grant also includes study of and training in social and behavioral research, which will be conducted through the Institute of Human Virology and the African University of Science and Technology, both in Nigeria, and the Center for Infectious Diseases Research in Zambia.